Yun Zhang

Dr. Yun Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2025 in Gut Microbes
Verified
Journal Article
Open access
CZCheng Zhang
Cheng Zhang
SCShiyin Chen
Shiyin Chen
ZWZhien Wang
Zhien Wang
JZJian Zhang
Jian Zhang
WYWenqiao Yu
Wenqiao Yu
TLTingbo Liang
Tingbo Liang
Severe acute pancreatitis (SAP)-induced intestinal bacterial translocation and enterogenic infection are among the leading causes of mortality in patients. However, the mechanisms by which SAP disrupted the intestinal barrier and led to bacterial translocation remained unclear. Therefore, we employed multi-omics analysis including microbiome, metabolome, epigenome, transcriptome, and mass cytometry (CyTOF) to identify potential targets, followed by functional validation using transgenic mice. The integrated multi-omics analysis primarily indicated overgrowth of intestinal flagellated bacteria, upregulation of intestinal Toll-like receptor 5 (TLR5) and acute inflammatory response, and increased infiltration of intestinal high-expressing TLR5 lamina propria dendritic cells (TLR5hi LPDC) after SAP. Subsequently, intestinal flagellin-TLR5 signaling was activated after SAP. Intestinal barrier disruption, bacterial translocation, and helper T cells (Th) differentiation imbalance caused by SAP were alleviated in TLR5 knocked out (Tlr5−/−) or conditionally knocked out on LPDC (Tlr5ΔDC) mice. However, TLR5 conditional knockout on intestinal epithelial cells (Tlr5ΔIEC) failed to improve SAP-induced bacterial translocation. Moreover, depletion of LPDC and regulatory T cells (Treg) ameliorated bacterial translocation after SAP. Our findings identify TLR5 on LPDC as a potential novel target for preventing or treating intestinal bacterial translocation caused by SAP.

21 January 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
JZJian Zhang
Jian Zhang
WYWen‐Qiao Yu
Wen‐Qiao Yu
TWTao Wei
Tao Wei
CZCheng Zhang
Cheng Zhang
LWLiang Wen
Liang Wen
TLTingbo Liang
Tingbo Liang

11 February 2021 in Surgical Infections
Verified
Journal Article
Closed access
JZJian Zhang
Jian Zhang
WYWen-Qiao Yu
Wen-Qiao Yu
WCWen Chen
Wen Chen
TWTao Wei
Tao Wei
CWChao-Wei Wang
Chao-Wei Wang
TLTingbo Liang
Tingbo Liang
Background: Delayed treatment of seriously infected patients results in increased mortality. However, antimicrobial therapy for the initial 24 to 48 hours is mostly empirically provided, without evidence regarding the causative pathogen. Whether empiric anti-enterococcal therapy should be administered to treat intra-abdominal infection (IAI) before obtaining culture results remains unknown. We performed a meta-analysis to explore the effects of empiric enterococci covered antibiotic therapy in IAI and the risk factors for enterococcal infection in IAI. Methods: We searched multiple databases systematically and included 23 randomized controlled trials (RCTs) and 13 observational studies. The quality of included studies was assessed, and the reporting bias was evaluated. Meta-analysis was performed using random effects or fixed effects models according to the heterogeneity. The risk ratio (RR), odds ratio (OR), and 95% confidence interval (CI) were calculated. Results: Enterococci-covered antibiotic regimens provided no improvement in treatment success compared with control regimens (RR, 0.99; 95% CI, 0.97–1.00; p = 0.15), with similar mortality and adverse effects in both arms. Basic characteristic analysis revealed that most of the enrolled patients with IAI in RCTs were young, lower risk community-acquired intra-abdominal infection (CA-IAI) patients with a relatively low APACHE II score. Interestingly, risk factor screening revealed that malignancy, corticosteroid use, operation, any antibiotic treatment, admission to intensive care unit (ICU), and indwelling urinary catheter could predispose the patients with IAI to a substantially higher risk of enterococcal infection. “Hospital acquired” itself was a risk factor (OR, 2.81; 95% CI, 2.34–3.39; p < 0.001). Conclusion: It is unnecessary to use additional agents empirically to specifically provide anti-enterococcal coverage for the management of CA-IAI in lower risk patients without evidence of causative pathogen, and risk factors can increase the risk of enterococcal infection. Thus, there is a rationale for providing empiric anti-enterococcal coverage for severely ill patients with CA-IAI with high risk factors and patients with hospital-acquired intra-abdominal infection (HA-IAI).

31 August 2023 in Journal of Nutritional Science and Vitaminology
Verified
Journal Article
Open access
PDF file
TWTingting Wang
Tingting Wang
QXQin Xu
Qin Xu
YCYang Cao
Yang Cao
CZCheng Zhang
Cheng Zhang
SCShiyin Chen
Shiyin Chen
TLTingbo Liang
Tingbo Liang
Luteolin (LU), a natural compound, has diverse bioactivities; it alleviates lipid accumulation by enhancing the oxidation of fatty acids in nonalcoholic fatty liver disease (NAFLD). Mitochondrial dysfunction promotes the development of steatosis in NAFLD. However, few studies have focused on the mechanism by which LU affects mitochondrial function in NAFLD. In the present study, we investigated whether LU could ameliorate hepatic steatosis and affect mitochondrial function in Western diet-fed mice. After LU treatment, the indicators of hepatic function and markers of mitochondrial biogenesis were evaluated. The results showed that LU intervention 1) decreased the levels of serum triglyceride, total cholesterol, alanine aminotransferase, and low-density lipoprotein cholesterol; 2) increased the succinate dehydrogenase activity of mitochondrial enzyme; and 3) increased mitochondrial biogenesis by upregulating the AMPK/PGC-1α pathway. Therefore, LU might have the potential to prevent NAFLD.

10 April 2019 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
WYWen-Qiao Yu
Wen-Qiao Yu
SZShao-Yang Zhang
Shao-Yang Zhang
SFShui-Qiao Fu
Shui-Qiao Fu
QFQing-Hui Fu
Qing-Hui Fu
WLWei-Na Lu
Wei-Na Lu
TLTingbo Liang
Tingbo Liang
Objective This study demonstrated that dexamethasone (DEX) protects the endothelial glycocalyx from damage induced by the inflammatory stimulus tumor necrosis factor-α (TNF-α) during severe acute...

1 December 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
HLHui Li
Hui Li
SXShengzhi Xie
Shengzhi Xie
XZXuyi Zhang
Xuyi Zhang
YXYixin Xia
Yixin Xia
YZYun Zhang
Yun Zhang
LWLei Wang
Lei Wang